Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Exclusive: China startup CirCode gets clearance for trial of circular RNA therapy

Summary by endpoints.news
CirCode Biomed, a Chinese startup working on an experimental class of genetic medicines known as circular RNA, has received the FDA's blessing to begin a clinical trial in the US, the company told Endpoints News ...
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.Cross Cancel Icon

1 Articles

endpoints.newsendpoints.news

Exclusive: China startup CirCode gets clearance for trial of circular RNA therapy

CirCode Biomed, a Chinese startup working on an experimental class of genetic medicines known as circular RNA, has received the FDA's blessing to begin a clinical trial in the US, the company told Endpoints News ...

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

endpoints.news broke the news in on Monday, March 16, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Medical icon

Medical

FDA icon

FDA

United States icon

United States

Health & Medicine icon

Health & Medicine

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal